Experience of using Afobazole in the treatment of pathological anxiety in general practice

Медицинский совет

卷:0

T. E. Nikitina¹  I. N. Agamamedova¹ 

[1] Moscow Research Institute of Psychiatry, Russia's Ministry of Health;

关键词: тревожные расстройства;    селективные анксиолитики;    афобазол;    anxiety disorders;    selective anxiolytics;    afobazole;   

DOI  :  10.21518/2079-701X-2014-5-70-73

来源: DOAJ

【 摘 要 】

The effect of daily 30 mg dose of Afobazole was evaluated in 35 patients (26 women and 9 men) aged 18 to 60 years (mean age 44.7 years) with pathological anxiety. By the end of week 4 therapeutic remission was observed in 68.6% of patients: marked improvement in 22.9% of patients, and moderate improvement in 45.7% of patients. Afobazole therapy was not generally accompanied by side effects or sedation allowing patients to maintain usual daily activities and contributed to high level of adherence.

【 授权许可】

Unknown